JPRN-jRCT2080221672未知3 期
Phase3 study of T-1220 in the patients with bacterial infectious disease-Open label, multi-center study
Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)0 个研究点开始时间: 2011年12月14日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 15age old（—）
- 性别
- All
入选标准
- •(1)Sex:male or female
- •(2)Age: 20 years and older for adult and 28 days to 16 years old (inclusive) for child
- •(3)Outpatient or inpatient: inpatient
- •(4)Presence of definite symptom/findings of infectious disease
排除标准
- •(1)Medical history of allergy to any beta-lactam antibacterial agents.
- •(2)Patient with infectious mononucleosis.
- •(3)Pregnant females, females wishing to become pregnant or being possibly pregnant, and lactating females.
- •(4)Others.
研究者
相似试验
已完成
3 期
Phase III study of FTB-8127 in patients with post-herpetic neuralgia (A placebo-controlled, multicenter, double-blind, parallel-group study)Post-herpetic neuralgiaJPRN-jRCT2080220444FUSO Pharmaceutical Industries, Ltd.135
已完成
2 期
Phase 2 study of BKM120 in patients with advanced esophagus cancerJPRN-UMIN000011217ational Cancer Center Hospital East41
暂停
1 期
TAS0313 Phase I/II studySolid tumor (urothelial carcinoma, and so on)JPRN-jRCT2080223768Taiho Pharmaceutical Co., Ltd.130
未知
2 期
Phase II clinical study of TY-51924 in patients with acute myocardial infarction - Pilot studyAcute myocardial infarctionJPRN-jRCT2080221349TOA EIYO LTD.
未知
2 期
Proof of concept study of TY-51924 in patients with acute myocardial infarctioAcute myocardial infarctionJPRN-jRCT2080221705TOA EIYO LTD.100